BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
Authors
Keywords
Thienodiazepine, JQ1, Mesenchymal stem cell, Growth inhibition, Cell cycle arrest, Gene regulation, WNT
Journal
Stem Cell Research & Therapy
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-01
DOI
10.1186/s13287-016-0278-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
- (2015) M. Boi et al. CLINICAL CANCER RESEARCH
- BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice
- (2015) Erica Korb et al. NATURE NEUROSCIENCE
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
- (2015) P L Garcia et al. ONCOGENE
- An Overview of Neural Differentiation Potential of Human Adipose Derived Stem Cells
- (2015) Hossein Salehi et al. Stem Cell Reviews and Reports
- Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together with Lefty1
- (2015) Gillian A. Horne et al. STEM CELLS AND DEVELOPMENT
- JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer
- (2015) Haifeng Qiu et al. Oncotarget
- GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1
- (2015) Krishan Kumar et al. Scientific Reports
- An Overview of Neural Differentiation Potential of Human Adipose Derived Stem Cells
- (2015) Hossein Salehi et al. Stem Cell Reviews and Reports
- Neural Differentiation of Human Adipose Tissue-Derived Stem Cells Involves Activation of the Wnt5a/JNK Signalling
- (2015) Sujeong Jang et al. Stem Cells International
- Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)
- (2015) Harald Herrmann et al. Oncotarget
- BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
- (2015) Anton George Henssen et al. Oncotarget
- BET Protein Inhibitor JQ1 Attenuates Myc-Amplified MCC Tumor Growth In Vivo
- (2014) Q. Shao et al. CANCER RESEARCH
- The roles of mesenchymal stem cells in tumor inflammatory microenvironment
- (2014) Zhao Sun et al. Journal of Hematology & Oncology
- Bromodomain and Extraterminal Proteins Suppress NF-E2-Related Factor 2-Mediated Antioxidant Gene Expression
- (2014) C. Michaeloudes et al. JOURNAL OF IMMUNOLOGY
- Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
- (2014) S. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle
- (2014) François Lamoureux et al. Nature Communications
- BET Bromodomain Inhibition Triggers Apoptosis of NF1-Associated Malignant Peripheral Nerve Sheath Tumors through Bim Induction
- (2014) Amish J. Patel et al. Cell Reports
- Bromodomains as therapeutic targets in cancer
- (2013) I. Barbieri et al. Briefings in Functional Genomics
- The Kinase-Independent, Second Life of CDK6 in Transcription
- (2013) Tobias Otto et al. CANCER CELL
- Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
- (2013) Yung-Luen Yu et al. EMBO Molecular Medicine
- The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis
- (2013) Anna C. Belkina et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Making of I-BET762, a BET Bromodomain Inhibitor Now in Clinical Development
- (2013) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1
- (2013) Helen Jayne Susan Stewart et al. Cancer Medicine
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- Place your BETs: the therapeutic potential of bromodomains
- (2012) R.K. Prinjha et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
- (2011) XiaoDong Huang et al. MOLECULAR CELL
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells
- (2009) Hye Jin Jin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Embryonic Stem Cell Marker Expression Pattern in Human Mesenchymal Stem Cells Derived from Bone Marrow, Adipose Tissue, Heart and Dermis
- (2009) Una Riekstina et al. Stem Cell Reviews and Reports
- Wnt signaling controls the fate of mesenchymal stem cells
- (2008) Ling Ling et al. GENE
- The Bromodomain Protein Brd4 Stimulates G1Gene Transcription and Promotes Progression to S Phase
- (2008) Kazuki Mochizuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In Vitro Senescence of Rat Mesenchymal Stem Cells is Accompanied by Downregulation of Stemness-Related and DNA Damage Repair Genes
- (2008) Umberto Galderisi et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started